The Committee on the Clinical Application of Cardiac Biomarkers (C-CB) of the IFCC represents international groups from laboratory medicine, cardiology and emergency medicine involved with providing global educational guidance pertaining to the analytical and clinical applications of cardiac biomarkers. Although the recently published "2020 European Society of Cardiology (ESC) guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation" are extremely useful, our presentations will delineate specific concerns regarding the guidance for the use of high-sensitivity cardiac troponin. The concerns we will address are relevant to the international laboratory medicine community

Please ensure you register to attend the live event and have access to the recording and the Certificate

Schedule: the webinar lasts 90 minutes: 20 min per speaker plus 20 min panel discussion

Date: 29^th January 2021

Time Zones: Live presentations starting at 7:30 AM CST – MN time; 2:30 PM CET - European time; 1:30 GMT - UK Time; 9:30 PM CST - Beijing Time
Important: Please ensure that you carefully determine the time that the presentation will start in your global time zone. To calculate this, you can use the time zone converter tool at www.timeanddate.com/worldclock/converter.html.

Recorded webinar: available on demand.

Certificate of Participation: available for all registrants 

Click here to register to the webinar

Don’t miss it! A limit of 5000 attendees.

IFCC Information Guide on COVID-19

Click aquí para descargar el Resumen traducido de la Guía de Información de la IFCC sobre COVID-19
Kliknutím zde stáhnete českou verzi IFCC informačního  souhrnu o COVID 19 z 16 . dubna 2020

Coronavirus disease 2019, abbreviated to COVID-19, is an emerging global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As the number of individuals infected with COVID-19 continues to rise globally and healthcare systems become increasingly stressed, it is clear that the clinical laboratory will play an essential role in this crisis, contributing to patient screening, diagnosis, monitoring/treatment, as well as epidemiologic recovery/surveillance. This guide aims to organize relevant available information on laboratory screening, testing protocols, diagnosis, and other general information on COVID-19 for laboratory professionals, including links to helpful resources and interim guidelines. It will be continually updated as new guidelines and literature become available.

Click here to access to the different chapters of the IFCC Guide 

IFCC VIRTUAL CONFERENCE
15 - 17 FEBRUARY 2021

Click on the image to download the preliminary programme

EARLY Registration Fee  by 20th January 2021! Register now and Take advantage of the best registration fees!

IFCC VIRTUAL CONFERENCE
15 - 17 FEBRUARY 2021

Click on the image to download the preliminary programme

EARLY Registration Fee  by 20th January 2021! Register now and Take advantage of the best registration fees!

Education and Management Division

• Committee on Point of Care Testing (C-POCT): one corporate member position - time in office 2021-2023. 
  The deadline to receive nominations and supporting documents has been extended to 20^th January 2021.
• Committee on Clinical Molecular Biology Curriculum (C-CMBC): one member position - time in office 2021-2023.
  Deadline to receive nominations and supporting documents: 15^th January 2021.

=================

Emerging Technologies Division

• Committee on Emerging Technologies in Pediatric Laboratory Medicine (C-ETPLM): one member position - time in office 2021-2023.
  Deadline to receive nominations and supporting documents: 15^th February 2021.

=================

Applications for these positions should be submitted by IFCC members (National Societies or Corporate members). If you are interested, please refer to your National Representative or Corporate Representative for information on procedures for nominations. Find your representative HERE

For further information on the open Calls for Nominations, please visit the IFCC Call for Nominations page.

=================

IFCC Information Guide on COVID-19

Click aquí para descargar el Resumen traducido de la Guía de Información de la IFCC sobre COVID-19
Kliknutím zde stáhnete českou verzi IFCC informačního  souhrnu o COVID 19 z 16 . dubna 2020

Coronavirus disease 2019, abbreviated to COVID-19, is an emerging global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As the number of individuals infected with COVID-19 continues to rise globally and healthcare systems become increasingly stressed, it is clear that the clinical laboratory will play an essential role in this crisis, contributing to patient screening, diagnosis, monitoring/treatment, as well as epidemiologic recovery/surveillance. This guide aims to organize relevant available information on laboratory screening, testing protocols, diagnosis, and other general information on COVID-19 for laboratory professionals, including links to helpful resources and interim guidelines. It will be continually updated as new guidelines and literature become available.

Click here to access to the different chapters of the IFCC Guide 

Click here to watch Prof Adeli's Season's Greetings to the IFCC family.

Never respond to requests for personal information via email. Legitimate organizations will never ask for passwords, credit card numbers, or other personal information in an email.  If you receive an email requesting this kind of information, DO NOT RESPOND, DO NOT REPLY, DO NOT CLICK ON LINKS OR IMAGES, and DO NOT OPEN ANY ATTACHMENTS with the message.  If you think the email is legitimate, contact the company through their official contacts to confirm. Updating your systems with good security software can help defend data, users, systems, and companies from a wide range of risks.

Remember that the IFCC never requests money or credit card numbers, passwords, account information, or other personal information.

IFCC eNews: December 2020
PDF version	Flip-page version
	Note for eMagStudio publications: the type-in fields for the "Search" and "Go to page" functions are not enabled in full-screen mode.

IN THIS ISSUE:

• EDITORIAL
  • Message from the eNews editor
• THE VOICE OF IFCC
  • Message from the IFCC President - December 2020
  • 10th Beginners’ Course in Molecular Diagnostics 
  • Update from the IFCC Committee on Clinical Laboratory Management
• IFCC: THE YOUNG SCIENTISTS
  • The 52nd Congress of the Italian Society of Clinical Chemistry and Laboratory Medicine (SIBioC) – Young Scientists session
  • Mentorship interview
• CONTRIBUTE TO IFCC eNEWS
  • Twenty-four teams receive global recognition for Healthcare excellence in 2020
  • Reducing Patient Risk and Enhancing Care through the Development and Implementation of a New Chest Pain Pathway, Expedited by and for the COVID-19
  • Kidney Check: The next generation of surveillance for Hypertension, Diabetes and Chronic Kidney Disease
  • Early Diagnosis and Improved Management of Patients with Diabetes through Strategic and Automated Test Algorithms via Primary Care
  • Vaccine boom: glimmers of hope
• NEWS FROM REGIONAL FEDERATIONS AND MEMBER SOCIETIES
  • News from the Japan Society of Clinical Chemistry (JSCC): 2020 JSCC Academic Award
  • XIII Congreso Uruguayo de Bioquímica Clínica
  • Updates on EFLM publications
  • 18th Annual Conference of the Greek Society of Clinical Chemistry - Clinical Biochemistry
• IFCC WELCOMES A NEW CORPORATE MEMBER
  • LumiraDx
• IFCC'S CALENDAR OF CONGRESSES, CONFERENCES
  • Calendar of IFCC Congresses/Conferences and Regional Federations' Congresses
  • Calendar of events with IFCC auspices